Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety

Abstract

Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing prevalence. They remain the leading causes of morbidity and mortality worldwide. The use of medicinal herbs continues to be an alternative treatment approach for several diseases including CVDs. Currently, there is an unprecedented drive for the use of herbal preparations in modern medicinal systems. This drive is powered by several aspects, prime among which are their cost-effective therapeutic promise compared to standard modern therapies and the general belief that they are safe. Nonetheless, the claimed safety of herbal preparations yet remains to be properly tested. Consequently, public awareness should be raised regarding medicinal herbs safety, toxicity, potentially lifethreatening adverse effects, and possible herb-drug interactions. Over the years, laboratory data have shown that medicinal herbs may have therapeutic value in CVDs as they can interfere with several CVD risk factors. Accordingly, there have been many attempts to move studies on medicinal herbs from the bench to the bedside, in order to effectively employ herbs in CVD treatments. In this review, we introduce CVDs and their risk factors. Then we overview the use of herbs for disease treatment in general and CVDs in particular. Further, data on the ethnopharmacological therapeutic potentials and medicinal properties against CVDs of four widely used plants, namely Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum, are gathered and reviewed. In particular, the employment of these four plants in the context of CVDs, such as myocardial infarction, hypertension, peripheral vascular diseases, coronary heart disease, cardiomyopathies, and dyslipidemias has been reviewed, analyzed, and critically discussed. We also endeavor to document the recent studies aimed to dissect the cellular and molecular cardio-protective mechanisms of the four plants, using recently reported in vitro and in vivo studies. Finally, we reviewed and reported the results of the

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial

“…Astragalosides reduce oxidative damage by reducing MDA, maintain SOD and reduce free radical‐induced myocardial cell damage, prevent cell death by blocking the influx of Ca 2+ , and open mitochondrial KATP channel to reduce apoptosis 24 . It is also reported that astragaloside IV has positive inotropic effect on left ventricular ejection in patients with congestive HF 25 . Among the components of Salvia miltiorrhiza , tanshinone IIA can reduce the activation of angiotensin II‐induced β‐catenin and IGF‐2R pathways, apoptosis and Estrogen Receptors‐induced cardiac remodelling in cardiac fibroblasts, 26 and so on.…”

“…22 As the effective components of QSYQ, Astragalus mongholicus (NAG, 3-hydroxybutyric acid, 24 It is also reported that astragaloside IV has positive inotropic effect on left ventricular ejection in patients with congestive HF. 25 Among the components of Salvia miltiorrhiza, tanshinone IIA can reduce the activation of angiotensin II-induced β-catenin and IGF-2R pathways, apoptosis and Estrogen Receptors-induced cardiac remodelling in cardiac fibroblasts, 26 and so on. QSYQ has similar effects to aspirin in the secondary prevention of myocardial infarction.…”

Chinmedomics, a new strategy for evaluating the therapeutic efficacy of herbal medicines

“…With the prevalence of herbal medicines use in modern medicinal systems, herbal medicines are still not subject to the same surveillance and regulation as conventional drugs for the reason that they are viewed as being natural and therefore safe ( Shaito et al, 2020 ). Nonetheless, the safety of herbal medicines yet remains to be properly validated since some herbal medicines may have adverse outcomes and induce possible herb-drug interactions ( Li & Wang, 2020 ).…”

Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats

“…The synthetic drugs including statins and ß-blockers show undesirable adverse effects in the CVD clinics. The cardiovascular drug market is severely impacted by the scarcity of new potential alternative drugs (Shaito et al, 2020). Herbal medicines, in addition to their traditional values, also hold great public and medical interest worldwide as sources of novel lead compounds for cardiovascular drug development (Liperoti et al, 2017).…”